ArticleEuropean journal of pediatrics2026
Cortical structure alterations in toddlers with different severities of congenital heart disease: a cross-sectional study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to characterise the cortical structure in toddlers with congenital heart disease (CHD) of varying severities and to investigate its associations with preoperative laboratory values and neurodevelopmental outcomes. A cohort of 109 toddlers with CHD and 56 healthy controls (HCs) underwent magnetic resonance imaging between August 2021 and December 2023. All toddlers with CHD were assessed using the Gesell Developmental Schedules and stratified into mild, moderate, and severe groups. Generalised linear models were used to compare cortical structural (grey matter volume (GMV) and thickness) differences across CHD severity groups and HCs and to examine their relationships with preoperative laboratory values and neurodevelopmental outcomes. Compared with HCs, toddlers with mild and moderate-to-severe CHD exhibited reduced total brain volume and total GMV. Significant reductions in cortical GMV and thickness were observed in specific brain regions (p < 0.001, family-wise error corrected). Altered cortical structures demonstrated overlapping spatial distributions between the mild and moderate-to-severe CHD groups. In the mild and moderate-to-severe CHD groups, regional alterations were correlated with scores across multiple neurodevelopmental domains (adaptive, gross motor, and fine motor skills), and haemoglobin levels were associated with cortical thickness in the right superior frontal area (β = 0.422; p
conclusionToddlers with CHD exhibit GMV and cortical thickness variations across all CHD severity levels in this study. Notably, toddlers with mild CHD may demonstrate alterations comparable to those in the moderate-to-severe group at this developmental stage. These cortical alterations may merit early consideration during neurodevelopmental trajectories, irrespective of CHD severity. WHAT IS KNOWN: • While neurodevelopmental risks and behavioural abnormalities in children with complex CHD are well-established, less is known about the neuroanatomical alterations and neurodevelopmental outcomes of those with mild CHD. WHAT IS NEW: • Toddlers with CHD exhibit similar cortical structural alterations across all severity groups in this study. • Cortical structure was associated with haemoglobin levels and neurodevelopmental outcomes, suggesting it may lie on a pathway linking preoperative laboratory values to neurodevelopment. This positions it as a potential neuroimaging correlate of NDD and a candidate target for interventions aimed at improving outcomes.
Indexed as
Identifiers
42366252What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.